ISSN Print 2713-2757    ISSN Online 2713-2765
Extreme Medicine


Deputy General Director for Research,
Federal Scientific and Clinical Center for Specialized Types of Medical Aid and Medical Technologies (Moscow, Russia)

DSc (medicine), professor

Areas of expertise:

regenerative medicine, stem cells, neurosciences, targeted drug delivery

Special awards and honors:

Certificate of honor of the Mayor of Moscow (2020)
Certificate of honor of the Russian Academy of Science (2020)

Significant publications in last 5 years

1. Baklaushev VP, Durov OV, Kalsin VA, et al. Disease modifying treatment of spinal cord injury with directly reprogrammed neural precursor cells in non-human primates. World J Stem Cells 2021; 13(5): 452-469 DOI: 10.4252/wjsc.v13.i5.452 – Q2

2. Namestnikova DD, Gubskiy IL, Revkova VA, Sukhinich KK, Melnikov PA, Gabashvili AN, Cherkashova EA, Vishnevskiy DA, Kurilo VV, Burunova VV, Semkina AS, Abakumov MA, Gubsky LV, Chekhonin VP, Ahlfors J-E, Baklaushev VP, Yarygin KN Intra-Arterial Stem Cell Transplantation in Experimental Stroke in Rats: Real-Time MR Visualization of Transplanted Cells Starting With Their First Pass Through the Brain With Regard to the Therapeutic Action. Front Neurosci, 2021 Mar 2;15:641970. doi: 10.3389/fnins.2021.641970. eCollection 2021. – Q1

3. Revkova VA, Sidoruk KV, Kalsin VA <…> and Baklaushev VP. Spidroin Silk Fibers with Bioactive Motifs of Extracellular Proteins for Neural Tissue Engineering. ACS Omega. 2021 May 30;6(23):15264-15273. doi: 10.1021/acsomega.1c01576. PMID: 34151105; PMCID: PMC8210451. Q1

4. Byazrova M, Yusubalieva G, Spiridonova A, Efimov G, Mazurov D, Baranov K, Baklaushev V, Filatov A. Pattern of circulating SARS-CoV-2-specific antibody-secreting and memory B-cell generation in patients with acute COVID-19. Clin Transl Immunology. 2021 Jan 31;10(2):e1245. doi: 10.1002/cti2.1245. PMID: 33552508; PMCID: PMC7848539. Q1

5. Averyanov A, Koroleva I, Konoplyannikov M, Revkova V, Lesnyak V, Kalsin V, Danilevskaya O, Nikitin A, Sotnikova A, Kotova S, Baklaushev V. First-in-human high-cumulative-dose stem cell therapy in idiopathic pulmonary fibrosis with rapid lung function decline. Stem Cells Transl Med. 2020 Jan;9(1):6-16. doi: 10.1002/sctm.19-0037.